Pulmano, Rizel Mae .
HRN: 21-45-51 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2022
CEFUROXIME 1.5GM (VIAL)
06/07/2022
06/08/2022
IV
1.5g
Q8h
Post CS
Waiting Final Action
06/07/2022
CEFUROXIME 500MG (TAB)
06/07/2022
06/13/2022
PO
500mg
BID
Post CS
Waiting Final Action